Showing results (661-670 of 702) with videos related to

Sort By:
Pageof 71
Bone Marrow Transplantation|June 1, 1990
Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxinR B Montgomery, J Kurtzberg, A Rhinehardt-Clark, et al.
Neurology|February 19, 2000
Associations between circulating sex steroid hormones and cognition in normal elderly womenE B Drake, V W Henderson, F Z Stanczyk, et al.
European Journal of Immunology|September 1, 1994
Molecular and biological characterization of human 4-1BB and its ligandM R Alderson, C A Smith, T W Tough, et al.
International Immunology|August 1, 1996
Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individualsP D Katsikis, M E García-Ojeda, E S Wunderlich, et al.
Cell|May 7, 1993
Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factorR G Goodwin, M R Alderson, C A Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patientsS E Shackney, A A Pollice, C A Smith, et al.
Vaccine|April 8, 2004
DNA immunisation with minimalistic expression constructsS Moreno, L López-Fuertes, A J Vila-Coro, et al.
The Journal of Clinical Investigation|April 1, 1984
The biology of tumor growth in the non-Hodgkin's lymphomas. A dual parameter flow cytometry study of 220 casesS E Shackney, A M Levine, R I Fisher, et al.
Immunity|December 1, 1995
Identification and characterization of a new member of the TNF family that induces apoptosisS R Wiley, K Schooley, P J Smolak, et al.
Journal of Hematotherapy|April 1, 1995
Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative diseaseC A Smith, C Y Ng, H E Heslop, et al.
Pageof 71